Lingohr Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,100
Closed -$525K 106
2025
Q1
$525K Buy
+21,100
New +$552K 0.13% 76
2018
Q4
Sell
-38,682
Closed -$1.62M 128
2018
Q3
$1.62M Hold
38,682
1.09% 17
2018
Q2
$1.33M Hold
38,682
0.83% 76
2018
Q1
$1.3M Hold
38,682
0.81% 54
2017
Q4
$1.33M Hold
38,682
0.7% 53
2017
Q3
$1.29M Hold
38,682
0.66% 54
2017
Q2
$1.26M Hold
38,682
0.73% 60
2017
Q1
$1.26M Hold
38,682
0.69% 60
2016
Q4
$1.19M Buy
+38,682
New +$1.18M 0.73% 55

Other funds holding PFE

Lingohr Asset Management's PFE Position: Q2 2025 in Review

Lingohr Asset Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 21,100 shares — an estimated $525K sold.

Lingohr Asset Management first reported a position in PFE in Q4 2016 and held it in 9 quarters. The position peaked at $1.62M in Q3 2018. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Lingohr Asset Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Lingohr Asset Management sold 21,100 Pfizer shares in Q2 2025, an estimated $525K.
  • Lingohr Asset Management first reported a position in Pfizer in Q4 2016 and held it in 9 quarters.
  • Lingohr Asset Management's Pfizer position peaked at $1.62M in Q3 2018.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Lingohr Asset Management's 13F filing for Q2 2025, filed 8 Jul 2025.